1-3 of 3
Luis Chiriboga
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

Marissa Spino, Sylvia C. Kurz, Luis Chiriboga, Jonathan Serrano, Briana Zeck, Namita Sen, Seema Patel, Guomiao Shen, Varshini Vasudevaraja, Aristotelis Tsirigos, Carter M. Suryadevara, Joshua D. Frenster, Kensuke Tateishi, Hiroaki Wakimoto, Rajan Jain, Howard A. Riina, Theodore P. Nicolaides, Erik P. Sulman, Daniel P. Cahill, John G. Golfinos, Kumiko Isse, Laura R. Saunders, David Zagzag, Dimitris G. Placantonakis, Matija Snuderl, Andrew S. Chi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1261–1271.
https://doi.org/10.1158/1078-0432.CCR-18-2312
Published: 15 February 2019
View article titled, Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
Open the PDF for Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma in another window
Includes: Supplementary data
Journal Articles

NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma

Alex Panaccione, Michael T. Chang, Beatrice E. Carbone, Yan Guo, Christopher A. Moskaluk, Renu K. Virk, Luis Chiriboga, Manju L. Prasad, Benjamin Judson, Saral Mehra, Wendell G. Yarbrough, Sergey V. Ivanov
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (8): 2083–2095.
https://doi.org/10.1158/1078-0432.CCR-15-2208
Published: 14 April 2016
View article titled, NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma
Open the PDF for NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma in another window
Includes: Supplementary data
Journal Articles

Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

Sylvia Adams, Lina Kozhaya, Frank Martiniuk, Tze-Chiang Meng, Luis Chiriboga, Leonard Liebes, Tsivia Hochman, Nicholas Shuman, Deborah Axelrod, James Speyer, Yelena Novik, Amy Tiersten, Judith D. Goldberg, Silvia C. Formenti, Nina Bhardwaj, Derya Unutmaz, Sandra Demaria
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (24): 6748–6757.
https://doi.org/10.1158/1078-0432.CCR-12-1149
Published: 16 December 2012
View article titled, Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Open the PDF for Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer in another window
Includes: Supplementary data